173 related articles for article (PubMed ID: 17174179)
1. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ
J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179
[TBL] [Abstract][Full Text] [Related]
2. Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.
Iofina E; Langenberg R; Blindt R; Kühl H; Kelm M; Hoffmann R
Am J Cardiol; 2006 Oct; 98(8):1022-7. PubMed ID: 17027564
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
4. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Mintz GS; Tinana A; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ
Circulation; 2003 Sep; 108(11):1295-8. PubMed ID: 12952833
[TBL] [Abstract][Full Text] [Related]
5. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
Tanabe K; Serruys PW; Degertekin M; Grube E; Guagliumi G; Urbaszek W; Bonnier J; Lablanche JM; Siminiak T; Nordrehaug J; Figulla H; Drzewiecki J; Banning A; Hauptmann K; Dudek D; Bruining N; Hamers R; Hoye A; Ligthart JM; Disco C; Koglin J; Russell ME; Colombo A;
Circulation; 2005 Feb; 111(7):900-5. PubMed ID: 15710761
[TBL] [Abstract][Full Text] [Related]
6. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
[TBL] [Abstract][Full Text] [Related]
8. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
[TBL] [Abstract][Full Text] [Related]
9. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Weissman NJ; Fearnot NE; Park SW; Park SJ;
Circulation; 2003 Feb; 107(4):517-20. PubMed ID: 12566359
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow up of diabetic patients treated with sirolimus-eluting stents. An angiographic and three-dimensional intravascular ultrasound study.
Vaz VD; Abizaid A; Chaves A; Feres F; Ferreira E; Mattos L; Staico R; Abizaid A; Tanajura L; Centemero M; Mintz G; Sousa A; Sousa JE
J Invasive Cardiol; 2006 Apr; 18(4):142-6. PubMed ID: 16729398
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
Byrne R; Iijima R; Mehilli J; Pache J; Schulz S; Schömig A; Kastrati A
Rev Esp Cardiol; 2008 Nov; 61(11):1134-9. PubMed ID: 19000488
[TBL] [Abstract][Full Text] [Related]
13. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
Sousa JE; Costa MA; Abizaid A; Feres F; Seixas AC; Tanajura LF; Mattos LA; Falotico R; Jaeger J; Popma JJ; Serruys PW; Sousa AG
Circulation; 2005 May; 111(18):2326-9. PubMed ID: 15851603
[TBL] [Abstract][Full Text] [Related]
14. Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis.
Feres F; Munoz J; Abizaid A; Staico R; Kuwabara M; Mattos L; Centemero M; Maldonado G; Albertal M; Vaz VD; Ferreira E; Tanajura LF; Chaves A; Sousa A; Sousa JE
J Invasive Cardiol; 2005 Sep; 17(9):473-7. PubMed ID: 16145235
[TBL] [Abstract][Full Text] [Related]
15. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
[TBL] [Abstract][Full Text] [Related]
16. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
Suh JW; Park JS; Cho HJ; Kim MS; Kang HJ; Cho YS; Koo BK; Chung WY; Youn TJ; Chae IH; Choi DJ; Kim HS; Sohn DW; Oh BH; Park YB
Int J Cardiol; 2007 Apr; 117(1):31-6. PubMed ID: 17292498
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
[TBL] [Abstract][Full Text] [Related]
20. The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study.
Han SH; Ahn TH; Kang WC; Oh KJ; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
Am Heart J; 2006 Nov; 152(5):887.e1-7. PubMed ID: 17070150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
